Growth hormone secretagogues

Growth hormone secretagogues are research peptides investigated for their interaction with growth hormone signaling pathways, pulsatile GH release mechanisms, and hypothalamic–pituitary endocrine regulation. This category includes compounds commonly studied in laboratory models examining growth hormone secretion dynamics, IGF-1 pathway modulation, recovery signaling, and metabolic adaptation processes.
Key compounds in this category include CJC-1295 (no DAC), Ipamorelin, GHRP-2, and GHRP-6. These peptides are explored for their interaction with growth hormone–releasing hormone (GHRH) pathways and ghrelin receptor–mediated signaling mechanisms.
CJC-1295 is a modified GHRH analogue investigated for prolonged stimulation of endogenous growth hormone signaling, while Ipamorelin is a selective ghrelin receptor agonist commonly studied for pulsatile GH release models with reduced interaction outside the GH axis. GHRP-2 and GHRP-6 are widely researched growth hormone secretagogues evaluated for their effects on endocrine signaling, appetite-related pathways, and hypothalamic response mechanisms.
Explore compounds such as CJC-1295, Ipamorelin, GHRP-2, and GHRP-6, or browse related categories including metabolic research peptides and healing & recovery peptides for complementary peptide research pathways.
All products are supplied in lyophilized form and are intended for laboratory and analytical research purposes only.
For additional information on GH signaling pathways, peptide reconstitution, and endocrine research compounds, visit the Growth hormone–related peptides and peptide reconstitution guides.